Medindia

X

Imagenetix, Inc. Reports Year End Results

Monday, June 21, 2010 Corporate News J E 4
Advertisement


SAN DIEGO, June 21 Imagenetix, Inc. (OTC Bulletin Board: IAGX) announced today results for its fiscal year ended March 31, 2010. Net sales decreased 12% for the year to $6,596,000 from the $7,461,000 reported for the same period last year.

Gross profit as a percentage of sales decreased to 43% from 46% percent for the prior fiscal year. This decrease was primarily due to the sales mix, which included increased percentages for advertising allowances for the Company's branded retail products.

Net loss for the year was $697,000 or $.06 per share compared to a net profit of $430,000 or $.04 per share in the prior fiscal year.

Commenting on the results of the year, Mr. William Spencer, Imagenetix Chief Executive Officer said, "We continued to make progress in the mass market segment of our business by expanding the number of stores in which Celadrin« can be purchased. Activity in wholesale and distribution revenue came in lower which resulted in a year over year reduction in sales and a loss for the current year. We have already started shipment of Celadrinę to the nation's number one retailer at the start of the new fiscal year and are anticipating solid growth for fiscal 2011. Sales and profit growth are expected to primarily stem from our mass market related sales."

Imagenetix, based in San Diego, California, is an innovator of scientifically tested, natural-based, proprietary, bioceutical products developed to enhance human health on a global basis. Imagenetix develops and formulates proprietary over-the-counter topical creams, skincare products and nutritional supplements to be marketed globally through multiple channels of distribution. In addition, the company develops patentable compounds for entering into licensing agreements with pharmaceutical partners. Imagenetix is the creator of Inflame Away«-Celadrin«. Please visit, www.celadrin.com or www.imagenetix.net.

Certain matters in this news release are forward-looking statements which are subject to risks and uncertainties that could cause actual results to vary materially from those projected. Such risks and uncertainties include, but are not limited to, adverse fluctuations in future operating results due to a number of economic, competitive, and other factors, including, among other things, the size and timing of customer contracts, new or increased competition, changes in market demand, and seasonality of purchases of the company's products and services. Additional information with respect to these and other factors, which could materially affect the company and its operations, are included in the company's SEC filings, including its Form 10-K for the year ended March 31, 2010.

Imagenetix, Inc. Condensed Consolidated Statements of Operations (In thousands, except per share data)

SOURCE Imagenetix, Inc.
Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
FDA Marks First Anniversary of Tobacco Control Act
S
Surveillance Colonoscopy Should be Targeted to Hig...